XNET Overview

Validea's Small-Cap Growth Investor Model: The model, based on Motley Fool's strategy, identifies small-cap growth stocks with strong fundamentals and price performance.

StealthGas Inc. (GASS): This water transportation company saw its rating increase from 41% to 72%, indicating improved fundamentals and valuation; it operates a fleet of LPG carriers and other petroleum transport vessels.

Xunlei Ltd (ADR) (XNET): A software and programming small-cap stock that improved its rating from 67% to 87%, focusing on distributed cloud services and digital media content management.

About Motley Fool and Validea: Motley Fool, founded by David and Tom Gardner, provides investment insights, while Validea offers research based on legendary investors' strategies for long-term market outperformance.

U.S. Stock Futures: U.S. stock futures are down, with Dow futures dropping approximately 100 points on Thursday morning.

Coty Inc. Performance: Coty Inc. reported mixed fourth-quarter results, with revenue of $1.25 billion exceeding estimates but an adjusted loss of 5 cents per share falling short of expectations, causing shares to plummet 21.4% in pre-market trading.

Other Stocks Declining: Several other stocks also saw declines in pre-market trading, including Canadian Solar Inc. (-9.3%), Shineco, Inc. (-8.3%), and Rocket Pharmaceuticals, Inc. (-5.1%).

Market Trends: The overall market sentiment appears negative as multiple companies report disappointing earnings or guidance, leading to significant drops in their stock prices.

Nordson Corporation Performance: Nordson Corporation's shares rose 5.4% in pre-market trading after reporting third-quarter revenue of $741.51 million, exceeding analyst expectations of $722.57 million, with adjusted earnings per share at $2.73.

Other Gainers: Aethlon Medical saw a significant increase of 68.2%, while Tharimmune and Brazil Potash also reported substantial gains of 53.8% and 35.8%, respectively, due to positive announcements regarding stock offerings and agreements.

Notable Losers: ModivCare's shares plummeted 41.1% following its Chapter 11 filing for restructuring, while Coty Inc. fell 21.4% despite reporting higher-than-expected revenue but missing earnings estimates.

Market Overview: The pre-market trading session showed a mix of gains and losses among various stocks, reflecting reactions to recent financial results and corporate announcements.

Revenue Growth: Xunlei's revenue increased by 30.6% in the third quarter, driven by an 86% rise in its livestreaming services, which has become its largest income source.

Stock Performance: The company's stock has surged over fivefold in the past year, including a 96% increase in just three days following its earnings report for the second quarter.

Strategic Shift: Xunlei is moving back towards its video roots with a focus on overseas livestreaming markets, following its acquisition of sports media platform Hupu.

Investment Gains: The company reported significant gains from its investment in Arashi Vision Inc., contributing to a non-GAAP net profit increase, although its livestreaming and cloud computing segments are still operating at a loss.

Palo Alto Networks Financial Performance: Palo Alto Networks, Inc. reported strong financial results for Q4 of fiscal 2025, with revenue increasing by 16% year-over-year to $2.54 billion and adjusted earnings per share at 95 cents, surpassing analyst expectations.

Stock Movement: Following the positive earnings report, shares of Palo Alto Networks rose by 6.6% in pre-market trading, reaching $187.81.

Other Pre-Market Stock Movements: Several stocks experienced significant changes in pre-market trading, including Laser Photonics Corp, which surged 65.5%, and Color Star Technology Co Ltd, which gained 60.3%.

Declining Stocks: Conversely, some stocks saw declines, such as ALX Oncology Holdings Inc, which fell 19%, and Soligenix, Inc., which dipped 16.7% after previous gains.

U.S. Stock Futures: U.S. stock futures showed mixed results, with S&P 500 futures down approximately 0.1% on Monday morning.

Fabrinet's Performance: Fabrinet's shares fell 9.7% in pre-market trading despite reporting better-than-expected fourth-quarter results and projecting first-quarter revenue between $910 million to $950 million.

Other Stocks Declining: Several other stocks also experienced declines in pre-market trading, including Xunlei Limited (-8.4%), Precigen, Inc. (-5.8%), and Adecoagro S.A. (-4.5%).

FDA Approvals Impact: Tonix Pharmaceuticals saw a slight decline of 3.9% after receiving FDA approval for its fibromyalgia treatment, while other companies like Immatics NV also faced losses in their stock prices.